Martin Auster, Chief Financial Officer at Ventyx Biosciences, Inc. (VTYX), sold 52,941 shares at $32.26 ($1.7M) on 2023-09-05, disclosed to the SEC on 2023-09-07.
Open-market sale of $1.7M VTYX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.26 | 18,327 | $591K | 34.2% |
| 2 | $32.26 | 18,327 | $591K | 34.2% |
| 3 | $33.41 | 8,142 | $272K | 15.8% |
| 4 | $33.41 | 8,142 | $272K | 15.8% |
| 5 | $33.98 | 3 | $102 | 0.0% |
| Total | $32.61 avg | 52,941 |
| $1.7M |
| 100% |
| Filing → |
| VTYX | SELL | 2023-06-07 | $1.9M | — | Filing → |
| VTYX | SELL | 2023-04-27 | $2.1M | — | Filing → |
| VTYX | SELL | 2023-04-19 | $231K | — | Filing → |